awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34322552-D3588BA0-1AD3-4B3A-AA0B-4743242E0A17
Q34322552-D3588BA0-1AD3-4B3A-AA0B-4743242E0A17
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34322552-D3588BA0-1AD3-4B3A-AA0B-4743242E0A17
A randomized phase II study of gemcitabine and carboplatin with or without cediranib as first-line therapy in advanced non-small-cell lung cancer: North Central Cancer Treatment Group Study N0528
P2860
Q34322552-D3588BA0-1AD3-4B3A-AA0B-4743242E0A17
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34322552-D3588BA0-1AD3-4B3A-AA0B-4743242E0A17
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7012b9eaf15f43dfb972bd70b84b98be500d1808
P2860
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.